John A. McGrath

Active 1991–2025

207
Papers
25,444
Citations
92
h-index
201
i10-index

Citations

Citations per year for John A. McGrath1964: 5 citations1969: 1 citations1991: 1 citations1992: 9 citations1993: 9 citations1994: 20 citations1995: 9 citations1996: 53 citations1997: 65 citations1998: 67 citations1999: 88 citations2000: 77 citations2001: 71 citations2002: 120 citations2003: 110 citations2004: 130 citations2005: 98 citations2006: 137 citations2007: 137 citations2008: 141 citations2009: 185 citations2010: 180 citations2011: 193 citations2012: 147 citations2013: 160 citations2014: 147 citations2015: 158 citations2016: 139 citations2017: 161 citations2018: 136 citations2019: 595 citations2020: 657 citations2021: 682 citations2022: 478 citations2023: 334 citations2024: 689 citations2025: 270 citations2026: 5 citations1965–1968: no citations, so these years are not shown1970–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,073 citing papers, 25.6% of this breakdownUnited Kingdom: 786 citing papers, 9.7% of this breakdownGermany: 585 citing papers, 7.2% of this breakdownChina: 524 citing papers, 6.5% of this breakdownJapan: 330 citing papers, 4.1% of this breakdownItaly: 329 citing papers, 4% of this breakdownFrance: 322 citing papers, 4% of this breakdownCanada: 236 citing papers, 2.9% of this breakdownNetherlands: 235 citing papers, 2.9% of this breakdownAustralia: 224 citing papers, 2.8% of this breakdownSwitzerland: 198 citing papers, 2.4% of this breakdownSpain: 189 citing papers, 2.3% of this breakdown
0%25.6%Other 25.6%

Fields

  • Biochemistry, Genetics and Molecular Biology46.2%
  • Medicine38.6%
  • Immunology and Microbiology4.7%
  • Neuroscience3.2%
  • Nursing1.3%
  • Pharmacology, Toxicology and Pharmaceutics1.1%
  • Other4.9%

Topics

  • Skin and Cellular Biology Research6.4%
  • Autoimmune Bullous Skin Diseases2.5%
  • Dermatology and Skin Diseases2.2%
  • Cell Adhesion Molecules Research2%
  • Hair Growth and Disorders2%
  • Cancer, Hypoxia, and Metabolism1.9%
  • Other83%

Coauthors

All papers

Open in search
  1. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility

    Authors: , , , , , , , , , , , , , , , , , , , , , - British Journal of Dermatology 2020 cited by 780

  2. Germline NLRP1 Mutations Cause Skin Inflammatory and Cancer Susceptibility Syndromes via Inflammasome Activation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M. Denguezli, Ali Saâd, Sebastian Hiller, Bruno Reversade - Cell 2016 cited by 438

  3. Epidermolysis bullosa

    Authors: , , , , , , , , , , , , - Nature Reviews Disease Primers 2020 cited by 429

  4. A prenatal skin atlas reveals immune regulation of human skin morphogenesis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nana-Jane Chipampe, Keval Sidhpura, Justin Englebert, Laura Jardine, Gary Reynolds, Antony Rose, Vicky Rowe, Sophie Pritchard, Ilaria Mulas, James Fletcher, Dorin-Mirel Popescu, Elizabeth Poyner, Anna Dubois, Alyson Guy, Andrew Filby, Steven Lisgo, Roger A. Barker, Ian A. Glass, Jong-Eun Park, Roser Vento‐Tormo, Marina Nikolova, Peng He, John E. Lawrence, Josh Moore, Stéphane Ballereau, Claire Hale, Vijaya Baskar Mahalingam Shanmugiah, Dave Horsfall, Neil Rajan, John A. McGrath, Edel A. O’Toole, Barbara Treutlein, Omer Ali Bayraktar, Maria Kasper, Fränze Progatzky, Pavel Mazin, Jiyoon Lee, Laure Gambardella, Karl R. Koehler, Sarah A. Teichmann, Muzlifah Haniffa - Nature 2024 cited by 92

  5. Comorbidities of Keloid and Hypertrophic Scars Among Participants in UK Biobank

    Authors: , , , , , , , - JAMA Dermatology 2023 cited by 58

  6. Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations

    Authors: , , , , , , , , , , , , , , , , , , , , - Human Molecular Genetics 2005 cited by 849

  7. Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2013 cited by 334

  8. APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anna L. Bruckner, William A. Robinson, Cristina Has, Leena Bruckner‐Tuderman, Matthias Titeux, Marcel F. Jonkman, Ellie Rashidghamat, Su M. Lwin, Jemima E. Mellerio, John A. McGrath, Johann Bauer, Alain Hovnanian, Kenneth Y. Tsai, Andrew P. South - Science Translational Medicine 2018 cited by 132

  9. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies

    Authors: , , , , , , , , , , , , - Arthritis Research & Therapy 2020 cited by 66

  10. Prediction of Real-World Functional Disability in Chronic Mental Disorders: A Comparison of Schizophrenia and Bipolar Disorder

    Authors: , , , , , , , , , - American Journal of Psychiatry 2010 cited by 471

  11. Potential of Systemic Allogeneic Mesenchymal Stromal Cell Therapy for Children with Recessive Dystrophic Epidermolysis Bullosa

    Authors: , , , , , , , , , , , , , - Journal of Investigative Dermatology 2015 cited by 185

  12. Structure and function of skin, hair and nails

    Authors: , - Medicine 2013 cited by 176

  13. Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Farzin Farzaneh, Marcela Del Río, Jakub Tolar, Johann Bauer, Fernando Larcher, Michael Antoniou, Alain Hovnanian, Adrian J. Thrasher, Jemima E. Mellerio, Waseem Qasim, John A. McGrath - JCI Insight 2019 cited by 90

  14. Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - JCI Insight 2021 cited by 80

  15. Autoinflammatory Keratinization Disease With Hepatitis and Autism Reveals Roles for JAK1 Kinase Hyperactivity in Autoinflammation

    Authors: , , , , , , , , , , , , , , - Frontiers in Immunology 2022 cited by 37

  16. Lichen planus and lichenoid dermatoses

    Authors: , , , , , , , , - Journal of the American Academy of Dermatology 2018 cited by 179

  17. Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Iaisha Ali, Michael R. Ardern‐Jones, Charles D. Mitchell, Nigel Burrows, Ravinder Atkar, Cedric C. Banfield, A.B. Alexandroff, Caroline Champagne, Hywel Cooper, Sérgio Vañó-Galván, A.M. Molina‐Ruiz, Nerea Ormaechea Pérez, Girish K. Patel, A. E. Macbeth, Melanie C. Page, Alyson Bryden, Megan Mowbray, Shyamal Wahie, Keith Armstrong, Nicola Cooke, Mark Goodfield, Irene Man, David de Berker, Giles Dunnill, Anita Takwale, Archana S. Rao, Tee-Wei Siah, Rodney Sinclair, Martin Wade, Ncoza C. Dlova, Jane Setterfield, Fiona Lewis, Kapil Bhargava, Niall Kirkpatrick, Xavier Estivill, Catherine M. Stefanato, Carsten Flohr, Timothy D. Spector, Fiona M. Watt, Catherine Smith, Jonathan N. Barker, David A. Fenton, Michael A. Simpson, John A. McGrath - Nature Communications 2019 cited by 120

  18. Thrombospondin-1 Is a Major Activator of TGF-β Signaling in Recessive Dystrophic Epidermolysis Bullosa Fibroblasts

    Authors: , , , , , , , , , , , , - Journal of Investigative Dermatology 2019 cited by 71

  19. Innovations in the Treatment of Dystrophic Epidermolysis Bullosa (DEB): Current Landscape and Prospects

    Authors: , , , , - Therapeutics and Clinical Risk Management 2023 cited by 53

  20. WNT10A mutation causes ectodermal dysplasia by impairing progenitor cell proliferation and KLF4-mediated differentiation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2017 cited by 135

  21. Metabolic perturbations in fibrosis disease

    Authors: , , , , - The International Journal of Biochemistry & Cell Biology 2021 cited by 57

  22. Single‐cell transcriptomics in human skin research: available technologies, technical considerations and disease applications

    Authors: , , , , - Experimental Dermatology 2022 cited by 48

  23. ABE8e adenine base editor precisely and efficiently corrects a recurrent COL7A1 nonsense mutation

    Authors: , , , , , , , , , , , , , , , , , , - Scientific Reports 2022 cited by 41

  24. Fibroblast-Derived Dermal Matrix Drives Development of Aggressive Cutaneous Squamous Cell Carcinoma in Patients with Recessive Dystrophic Epidermolysis Bullosa

    Authors: , , , , , , , , , , , , , , - Cancer Research 2012 cited by 144